Company intelligence / Profile preview

Spindle Biotech

Toronto, Ontario, Canada

Ownership: Private
Development stage: Other

Overview

Spindle Biotech develops and commercializes proprietary RNA polymerase technology and high-throughput guide RNA arrays. Their platform enables high-yield and low-cost production of synthetic RNA and mRNA, which are used for research, vaccine manufacturing, and gene editing applications like CRISPR. The company functions primarily as a platform and tools provider.

Industry: Non-Drug Biotech

Partnerships

Applied DNA Sciences

Beyond the preview

Go deeper on Spindle Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spindle Biotech.

Explore the full profile